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Abstract. The purpose of this study is to evaluate the suitability of five different anesthetic protocols (isoflurane,
isoflurane–xylazine, pentobarbital, ketamine–xylazine, and ketamine–xylazine–vecuronium) for functional blood
flow imaging in the rat eye. Total retinal blood flow was measured at a series of time points using an ultrahigh-
speed Doppler OCT system. Additionally, each anesthetic protocol was qualitatively evaluated according to the
following criteria: (1) time-stability of blood flow, (2) overall rate of blood flow, (3) ocular immobilization, and
(4) simplicity. We observed that different anesthetic protocols produced markedly different blood flows.
Different anesthetic protocols also varied with respect to the four evaluated criteria. These findings suggest
that the choice of anesthetic protocol should be carefully considered when designing and interpreting functional
blood flow studies in the rat eye. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution
or reproduction of this work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.22.1.016005]
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1 Introduction
Measurement of small animal ocular blood flow is of significant
interest to the scientific and clinical research communities. This
interest is attributable to the importance of ocular blood flow as a
parameter in studies of ocular pathophysiology and its potential
to serve as an early marker of a variety of ocular diseases,
including age-related macular degeneration, diabetic retinopa-
thy, and glaucoma. The importance of ocular blood flow has
driven the development of multiple measurement technologies
including retinal/dynamic vessel analysis,1 microsphere meth-
ods,2–4 laser Doppler-based velocimetry5–8 and flowmetry,9–11
laser speckle imaging,11–13 magnetic resonance imaging
(MRI),14–16 color Doppler ultrasound imaging,17–19 and optical
coherence tomography (OCT).20–31 En face Doppler OCT, the
modality used in this study, is a noninvasive, OCT-based tech-
nique that measures the Doppler velocities in the en face plane.
In contrast to traditional Doppler OCT, which uses individual
cross-sectional images, en face Doppler OCT does not require
determination of the Doppler angle. Instead, in en face Doppler
OCT, total blood flow is obtained by segmenting the blood
vessels and integrating Doppler velocities in the en face
plane.26,28,32
Murine models are widely used to study the pathology of and
develop treatments for ocular diseases. Anesthesia is a common
requirement prior to small animal imaging, and it is well
known within the neuroscience community that different anes-
thetics elicit different cerebral blood flows.33–35 However, there
have been relatively few studies examining the influence of
anesthetic protocols on ocular blood flow in the rat. Muir and
Duong14 compared the effects of isoflurane andketamine–xylazine
on ocular blood flow in themouse eye. Using arterial spin labeling
(ASL) MRI they found that ketamine–xylazine anesthesia
(100 mg∕kg ketamine and 10 mg∕kg xylazine) had associated
blood flow values that were 29% lower (0.88 0.22 mL∕g∕min
versus 1.3 0.44 mL∕g∕min) in the retinal tissues (p < 0.01)
and 42% lower (4.3 1.9 mL∕g∕min versus 7.7 2.1 mL∕g∕
min) in the choroidal tissues (p < 0.01) compared to flows during
isoflurane anesthesia (1.1%). In another study using ASLMRI, Li
et al.15 measured total ocular blood flow in rats anesthetized under
twodifferent isofluranedosages.Under 1.0% isoflurane anesthesia
the basal blood flowwas 6.3 1.0 mL∕g∕min, while under 1.5%
isoflurane the basal blood flow was 9.3 2.7 mL∕g∕min. At the
resolutionused in that study, the reportedMRIbloodflowmeasure-
ments were a weighted average of the blood flows in the choroid
and retina.
The purpose of this study is to evaluate the suitability of dif-
ferent anesthetic protocols for functional blood flow imaging in
the rat eye; in large part, this study was motivated by the desire
to develop an anesthetic protocol allowing for repeatable, con-
trolled blood flow measurements in longitudinal studies. Using
an ultrahigh-speed en face Doppler OCT system, we quantita-
tively measure total retinal blood flow in male Sprague–Dawley
rats anesthetized with the following protocols: (1) isoflurane;
(2) isoflurane–xylazine, with xylazine delivered via intraperito-
neal (IP) injection; (3) pentobarbital via IP injection; (4) ket-
amine–xylazine via IP injection; and (5) ketamine–xylazine
in conjunction with vecuronium bromide (a paralytic agent),
with all three agents delivered via continuous rate infusion
(CRI). In addition to providing quantitative total retinal blood
flow at a series of time points, we evaluate each protocol
*Address all correspondence to: James G. Fujimoto, E-mail: jgfuji@mit.edu
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according to the following criteria: (1) time-stability of blood
flow, (2) overall rate of blood flow and its potential interference
with functional blood flow measurements, (3) ocular immobili-
zation, and (4) simplicity.
2 Methods
2.1 Animal Preparation and Imaging Protocol
Male Sprague–Dawley rats (Charles River Laboratories), whose
numbers and weights are described in Table 1, were used. The
animals were kept in the Massachusetts Institute of Technol-
ogy’s (MIT) Department of Comparative Medicine’s veterinary
housing unit and were given water and food ad libitum. All pro-
cedures were approved by MIT’s Committee on Animal Care
and abide with the National Institutes of Health guide for the
care and use of laboratory animals.
Anesthetic dosages and routes of administration are summa-
rized in Table 2. Dosages for ketamine–xylazine and pentobar-
bital, while close to surgical levels, were selected as such to
minimize ocular motion. For the ketamine–xylazine–vecuro-
nium regime, rats were anesthetized with 2% isoflurane prior
to venous catheterization. Isoflurane was discontinued after
the ketamine–xylazine CRI was initiated. After tracheal intuba-
tion was nonsurgically performed, ventilation was initiated fol-
lowed with vecuronium CRI (in addition to ketamine–xylazine
CRI). Note that immediately prior to the initiation of the ket-
amine–xylazine–vecuronium CRI, a bolus intravenous (IV)
injection of vecuronium was administered. Finally, for all IP
anesthetic protocols, so that time-transient behavior would be
apparent, maintenance dosages were not delivered subsequent
to the initial bolus injection.
After anesthesia, rats were placed in a custom holder that
allowed them to be securely manipulated during imaging. For
each rat, Doppler OCT measurements were repeatedly acquired
to create a time-series of blood flow values. Prior to each Doppler
OCT measurement, the OCT beam was manually aligned on the
animal’s eye to maximize signal strength. Throughout the pro-
cedure, the animal’s heart rate and blood oxygen saturation were
measured with a pulse oximeter (Nonin) and blood pressure
was measured using a tail cuff (Kent Scientific). Temperature
was measured using a rectal probe and was maintained with an
electronically controlled thermal blanket (Harvard Apparatus).
Intraocular pressure was measured using a rebound tonometer
(Icare, Finland) before each Doppler OCT acquisition. A mix
of medical air and oxygen was provided as needed to keep
blood oxygen saturation levels above 95%. For the ketamine–
xylazine–vecuronium protocol, rats were ventilated using the
Inspira Advanced Safety Ventilator (Harvard Apparatus).
2.2 OCT System and Data Acquisition
An ultrahigh-speed spectral domain OCT system was used to per-
form en face Doppler OCT measurements of total retinal blood
flow. The same system is described by Choi et al.28 and, therefore,
is only briefly summarized. The system uses a commercially
available superluminescent diode (Superlum, SLD-371) with a
full-width-at-half-maximum bandwidth of 55-nm and an 840-
nm central wavelength. A line scan camera (Basler Sprint
spL4096-140 km) with 832 illuminated pixels was used to
achieve an imaging speed of 244,000 A-scans per second. The
axial resolution and total imaging range, in tissue, were 5.7 μm
and 1.5 mm, respectively. OCT power incident on the cornea was
2.5 mW, and the system sensitivity was 99 dB.
Total retinal blood flow was calculated using a technique
described previously.28 In brief, a 200 μm × 200 μm area cen-
tered at the optic nerve head was repeatedly scanned at a 83-Hz
volume acquisition rate with 150 A-scans per B-scan, 25 B-
scans per volume (scan duty cycle of 0.85%), and 100 repeated
volumes per acquisition. Total retinal arterial blood flow was
calculated by segmenting the central retinal artery and integrat-
ing the axial velocity in the en face plane, avoiding the need to
measure Doppler angles. The volume acquisition rate used in
Table 1 Number and weight of rats by protocol.
Protocol Isoflurane Isoflurane–xylazine Pentobarbital Ketamine–xylazine IP
Ketamine–xylazine–
vecuronium CRI
Number 5 6 5 6 7
Weight (g) 325.4 11.0 251.0 5.7 276.8 10.2 252.0 10.4 299.0 22.6
Note: CRI, continuous rate infusion; IP, intraperitoneal.
Table 2 Summary of the dosages and methods of delivery.
Anesthetic protocol Dosage Method of delivery
Isoflurane 1.5% to 2.5% isoflurane Inhalation
Isoflurane–xylazine 2% isoflurane Inhalation for
isoflurane
8 mg∕kg xylazine IP bolus for
xylazine
Pentobarbital 50 mg∕kg pentobarbital IP bolus injection




1.5 mg∕kg vecuronium IV bolus injection




Note: CRI, continuous rate infusion; IP, intraperitoneal; IV,
intravenous.
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this study was >10× faster than typical heart rates encountered
in rats under anesthesia, which enabled accurate measurement of
mean total retinal arterial blood flow by averaging retinal arterial
blood flow over multiple cardiac cycles.
2.3 Subjective Evaluation of Anesthetic Protocols
Each anesthetic protocol was subjectively evaluated according
to the following criteria: (1) time-stability of blood flow,
(2) overall rate of blood flow, (3) immobilization of the eye,
and (4) simplicity. Criterion (1) is intended to capture whether
a given anesthetic protocol has a reasonable window of time, say
20 min, over which the blood flow values are reasonably con-
stant, trending neither higher nor lower; the existence of such a
time window is important for obtaining repeatable blood flow
measurements. For criterion (2), while it would be ideal to dis-
cuss retinal blood flow rates relative to those seen in unanesthe-
tized rats, to our knowledge such values have not been reported.
Thus, for the purposes of this study, we describe the blood flow
rate associated with a given anesthetic protocol relative to blood
flow rates produced by the other tested anesthetic protocols: if a
certain anesthetic protocol is associated with a higher blood flow
rate than the others, we will refer to its blood flow values as
“high.” We use the converse definition for “low” blood flow
rates. Criterion (3) is intended to capture whether a given anes-
thetic protocol facilitates eye imaging by minimizing ocular
motion: as discussed in subsequent sections, it is our experience
that with certain anesthetic protocols the rat eye tends to “drift,”
making it difficult to obtain good OCT beam alignment.
3 Results
Table 3 summarizes the measured physiological parameters,
separated according to anesthetic protocol. Figure 1 shows,
for each of the tested anesthetic protocols, total retinal blood
flow, heart rate, and mean blood pressure measurements as func-
tion of time. For a given anesthetic protocol, different style
markers correspond to different rats. Not all rats have the
same frequency of blood flow measurements, which is generally
a reflection of the difficulty of sufficiently stabilizing the eye for
imaging. Furthermore, due to the anesthetic agents’ half-lives,
the time over which the measurements were obtained was
shorter for the IP delivered protocols than for CRI and inhalation
protocols. For some blood flow measurements, the blood pres-
sure cuff failed to obtain measurements, and, consequently, not
all blood flow measurements have associated blood pressure
measurements. Furthermore, one rat imaged under ketamine–
xylazine IP did not have IOP measurements due to the
tonometer malfunctioning. Table 4 summarizes the qualitative
evaluation of the different anesthetic protocol with respect to
the criteria described in Sec. 2.3.
4 Discussion
With reference to Fig. 1, the blood flow measurements for the
isoflurane and isoflurane–xylazine anesthetic protocols were
markedly higher than for the other three anesthetic protocols.
This observation is consistent with MRI studies, as well as
the fact that isoflurane is a known vasodilator.14,15 When
using isoflurane alone, we found that eye motion made imaging
challenging. The relative scarcity of measurements collected
under isoflurane anesthesia is a reflection of this difficulty.
While we found that IP injection of xylazine in conjunction
with isoflurane significantly reduced eye motion, the vasodila-
tory effects of isoflurane may make it an unsuitable anesthetic
for investigating neurovascular coupling where vessel dilation is
coupled to the stimulus (as is the case with flicker light stimu-
lus). Finally, note that neither isoflurane nor isoflurane–xylazine
anesthesia showed strong time transients for blood flow, heart
rate, or blood pressure.
Pentobarbital was found to yield reasonably time-invariant
blood flows at rates lower than those observed when using iso-
flurane. However, heart rate and mean blood pressure under pen-
tobarbital appear to show a relatively large variation in values,
although no clear trend is observable. Finally, anesthesia using
pentobarbital did not reduce eye motion, making imaging diffi-
cult. One potential solution to eye motion, not explored in this
paper, is to combine pentobarbital with vecuronium.
The blood flow versus time plots measured with the ket-
amine–xylazine IP protocol exhibited a clear time-dependence,
with blood flow and mean blood pressure decreasing with time
and heart rate increasing with time. This time-dependence, pre-
sumably due to the IP bolus delivery, complicates the ability to
acquire repeatable measurements among different animals. In a
previous study examining ketamine–xylazine IP anesthesia (ket-
amine: 125 mg∕kg and xylazine: 10 mg∕kg) for adult rats (8- to
12-weeks old; 350 to 400 g), voluntary movement occurred
∼1.5 h after ketamine–xylazine injection and the half-life of
both ketamine and xylazine was found to be ∼1.3 h.36 The
time transients observed in our data are consistent with these
findings. Another interesting finding from that same study is
that ketamine and xylazine clearance was strongly reduced in
older rats (2.0- to 2.4-years old; 0.8 to 1.1 kg): in old rats,
the half-lives of ketamine and xylazine were found to be 8.5
Table 3 Summary of the measured physiological parameters.
Anesthetic protocol TRBF (μL∕min) HR (BPM) MBP (mmHg) IOP (mmHg) SO2 (%)
Isoflurane 8.2 2.1 358.5 36.8 98.9 12.9 10.8 1.3 98.1 1.4
Isoflurane–xylazine 8.9 2.1 326.5 22.3 72.4 14.0 9.4 0.8 95.4 1.4
Pentobarbital 4.7 1.3 422.8 30.9 93.5 24.3 10.1 1.0 98.6 1.1
Ketamine–xylazine IP 3.7 1.4 289.9 14.8 93.9 14.3 8.8 1.0 98.5 0.8
Ketamine–xylazine–vecuronium CRI 3.1 1.0 304.8 20.9 76.2 11.8 8.5 0.6 97.0 1.6
Note: All values are listed as mean standard deviation. TRBF, total retinal blood flow; HR, heart rate; BPM, beats per minute; MBP, mean blood
pressure; IOP, intraocular pressure; SO2, oxygen saturation; IP, intraperitoneal; CRI, continuous rate infusion.
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and 13 h, respectively. This suggests that the time-dependencies
observed in this study may change as a function of animal age.
Ketamine–xylazine–vecuronium anesthesia yielded low, rel-
atively stable blood flows. CRI largely removed the time tran-
sients that were observed with ketamine–xylazine IP delivery,
and heart rate and blood pressure were fairly constant in time.
Although not included in this study, we have found that at the
relatively low dose of ketamine–xylazine used in this anesthetic
protocol (20 mg∕kg∕h ketamine and 2 mg∕kg∕hr xylazine),
eye movement was too severe to perform OCT imaging. Rather
than increasing the dose of ketamine–xylazine (as we did in the
case of the ketamine–xylazine IP protocol), we chose to mini-
mize eye motion by adding vecuronium while maintaining the
minimal dose of ketamine–xylazine for anesthesia; this choice
was made so as to minimally perturb blood flow. A drawback of
the ketamine–xylazine–vecuronium protocol is the relative
complexity associated with delivering multiple drugs intra-
venously as well as the need to intubate and ventilate the animal
due to paralysis. These challenges are somewhat increased in
Fig. 1 Total retinal blood flow, heart rate, and mean blood pressure measurements as a function of time
for the five tested anesthetic protocols. For a given anesthetic protocol, different style markers corre-
spond to different rats. BPM, beats per minute; IP, intraperitoneal; CRI, continuous rate infusion.








Isoflurane ✓ High ✗ ✓
Isoflurane–xylazine ✓ High ✓ ✓
Pentobarbital ✓ Low ✗ ✓
Ketamine–xylazine IP ✗ Low ✓ ✓
Ketamine–xylazine–
vecuronium CRI
✓ Low ✓ ✗
Note: Check marks indicate that the anesthetic protocol was subjec-
tively determined to have favorable characteristics with respect to the
given criteria; cross marks indicate the converse. “High” and “low”
blood flow values were subjectively assessed relative to the other
anesthetic protocols, as described in Sec. 2.3. CRI, continuous
rate infusion; IP, intraperitoneal.
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longitudinal studies, which involve nonterminal procedures, and
therefore require that animals be carefully weaned off of the
paralytic. We believe, however, that the stability and ease-of-im-
aging may justify the complexity.
There are a number of important limitations to our study.
Certain physiological parameters, including PO2, PCO2, blood
glucose, and pH were not measured or controlled, in large part
because measurement of these parameters requires direct arterial
cannulation, which complicates the procedure, particularly in
longitudinal studies. Lacking knowledge of these parameters
means that it is possible that at times we were imaging in the
hyperoxic/hypoxic and/or hypercapniac/hypocapniac regimes.
Other parameters, such as blood pressure, were measured
using techniques known to be less accurate than invasive meth-
ods (e.g., we measured blood pressure using a blood pressure
cuff instead of via direct arterial cannulation). Furthermore,
in our study, only rats anesthetized with ketamine–xylazine–
vecuronium were ventilated, while ventilation could be used
in conjunction with any of the tested anesthetic protocols.
Because isoflurane is known to be a potent respiratory depres-
sant, potentially inducing hypercapnia during spontaneous
breathing, and because previous studies have shown that hyper-
capnia is associated with increased ocular blood flow due to vas-
odilation, the higher blood flows observed in rats anesthetized
with isoflurane may be partially due to hypercapnia, which
could be controlled in part by ventilation. While these limita-
tions in monitoring and physiological control prevent us from
ascribing the observed blood flow differences to the tested anes-
thetic agents, per se, they do not affect the goal of evaluating the
effects of the different anesthetic protocols, taken as a whole.
Moreover, a secondary aim of this study was to investigate anes-
thetic protocols commonly used in optical imaging of the small
animal eye. This is especially true when our study is considered
in the context of optical imaging studies of small animal retinal
blood flow, where the above parameters are rarely measured or
controlled. Another limitation of this study is that we did not test
different drug dosages or consider all of the various methods of
delivery. While such data would be informative, the number of
animals needed to perform this analysis serves as a high barrier.
Furthermore decreased dosages are likely to exacerbate ocular
motion, making optical imaging difficult. Other limitations of
the study include (1) that the protocols were evaluated using
criteria that emphasized measurement precision rather than
accuracy, which could lead to incorrect conclusions being
reached when the results of this study are extended to disease
models, and (2) that there was an absence of blood flow mea-
surements from unanesthetized rats, which would have served as
a baseline against with which the tested anesthetic protocols
could be compared. Both of these limitations could be addressed
in future studies by performing blood flow measurements using
the microsphere method; this method has the distinct advantage
that it can be performed in the absence of anesthesia. Despite
these limitations, we believe that this study makes a useful con-
tribution to the current functional blood flow imaging literature.
5 Conclusion
Measuring retinal blood flow in the small animal eye is impor-
tant for studies of retinal disease pathogenesis and pharmaceut-
ical development. However, anesthesia, which is a requirement
for ocular imaging in small animals, may alter ocular blood flow.
In this study, we used en face Doppler OCT to quantitatively
investigate the influence of five different anesthetic protocols
on total retinal blood flow in the rat. Additionally, each anes-
thetic protocol was qualitatively evaluated according to criteria
relevant to functional blood flow imaging studies. We observed
that different anesthetic protocols produced markedly different
blood flows and that different anesthetic protocols varied with
respect to the qualitative criteria. These findings suggest that the
choice of anesthetic protocol should be carefully considered
when designing and interpreting functional blood flow studies
in the small animal eye.
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